Desensitization to type I interferon in HIV-1 infection correlates with markers of immune activation and disease progression

Blood. 2009 May 28;113(22):5497-505. doi: 10.1182/blood-2008-11-190231. Epub 2009 Mar 19.

Abstract

Type I interferon (IFNalpha/beta) plays a complex role in HIV-1 infection and has been proposed alternately to have roles in either disease protection or progression. Although IFNalpha/beta plays crucial roles in regulating monocytes and dendritic cells, responsiveness of these cells to IFNalpha/beta in HIV-1 infection is poorly understood. We report significant defects in IFNalpha/beta receptor (IFNalpha/betaR) expression, IFNalpha signaling, and IFNalpha-induced gene expression in monocytes from HIV-1-infected subjects. IFNalpha/betaR expression correlated directly with CD4+ T-cell count and inversely with HIV-1 RNA level and expression of CD38 by memory (CD45RO+) CD8+ T cells, a measure of pathologic immune activation in HIV-1 infection associated with disease progression. In addition, monocytes from HIV-1-infected persons showed diminished responses to IFNalpha, including decreased induction of phosphorylated STAT1 and the classical interferon-stimulated gene produces MxA and OAS. These IFNalpha responses were decreased regardless of IFNalpha/betaR expression, suggesting that regulation of intracellular signaling may contribute to unresponsiveness to IFNalpha/beta in HIV-1 disease. Defective monocyte responses to IFNalpha/beta may play an important role in the pathogenesis of HIV-1 infection, and decreased IFNalpha/betaR expression may serve as a novel marker of disease progression.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use
  • Biomarkers / blood
  • Case-Control Studies
  • Cross-Sectional Studies
  • Disease Progression
  • Drug Resistance, Viral / immunology*
  • Female
  • HIV Infections / blood
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV-1* / immunology
  • Humans
  • Immunity, Active* / drug effects
  • Interferon Type I / therapeutic use*
  • Male
  • Middle Aged
  • Monocytes / metabolism
  • Monocytes / pathology
  • Receptors, Interferon / metabolism

Substances

  • Antiviral Agents
  • Biomarkers
  • Interferon Type I
  • Receptors, Interferon